EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Inflammation and epithelial–mesenchymal transition in a CFTR ‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip

Domenico Mattoscio iD, Luis A Baeza, Haiqing Bai, Tommaso Colangelo, Simone Castagnozzi, Marta Marzotto, Maria Concetta Cufaro, Virginia Lotti, Yu-Chieh Yuan, Matteo Mucci, Longlong Si, Mariachiara Zuccarini and 8 more

The FEBS Journal · 2025-10 · 292 (19) · 5086-5104

DOI: 10.1111/febs.70050 ↗

At a glance

Journal article in The FEBS Journal, published online on 2025-03-03. Written by Domenico Mattoscio and 19 co-authors. Institution: Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University, Chieti-Pescara, Italy. Major MEDLINE topics: Cystic Fibrosis Transmembrane Conductance Regulator, Epithelial-Mesenchymal Transition, Epithelial Cells, Inflammation. Cited 16 times so far (Crossref); 80 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCCIH NIH HHS, Fondazione per la Ricerca sulla Fibrosi Cistica, Associazione Italiana per la Ricerca sul Cancro.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cystic fibrosis (CF) is a genetic disease caused by mutations in the CF transmembrane conductance regulator ( CFTR ) gene, leading to chronic, unresolved inflammation of the airways due to uncontrolled recruitment of polymorphonuclear leukocytes (PMNs). Evidence indicates that CFTR loss‐of‐function, in addition to promoting a pro‐inflammatory phenotype, is associated with an increased risk of developing cancer, suggesting that CFTR can exert tumor‐suppressor functions. Three‐dimensional (3D) in vitro culture models, such as the CF lung airway‐on‐a‐chip, can be suitable for studying PMN recruitment, as well as events of cancerogenesis, that is epithelial cell invasion and migration, in CF. To gather insight into the pathobiology of CFTR loss‐of‐function, we generated CFTR‐knockout (KO) clones of the 16HBE14o‐ human bronchial cell line by CRISPR/Cas9 gene editing, and performed a comparative proteomic analysis of these clones with their wild‐type (WT) counterparts. Systematic signaling pathway analysis of CFTR‐KO clones revealed modulation of inflammation, PMN recruitment, epithelial cell migration, and epithelial–mesenchymal transition. Using a latest‐generation organ‐on‐a‐chip microfluidic platform, we confirmed that CFTR‐KO enhanced PMN recruitment and epithelial cell invasion of the endothelial layer. Thus, a dysfunctional CFTR affects multiple pathways in the airway epithelium that ultimately contribute to sustained inflammation and cancerogenesis in CF.

Subjects

MeSH terms (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorEpithelial-Mesenchymal TransitionEpithelial CellsInflammationCystic FibrosisBronchiHumansProteomicsCell LineCell MovementLab-On-A-Chip DevicesCRISPR-Cas SystemsNeutrophilsSignal TransductionMicrophysiological Systems

Author keywords

CRISPR/Cas9cystic fibrosisepithelial–mesenchymal transitionorgan‐on‐a‐chipproteomics

Substances

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Authors and institutions

  • Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University, Chieti-Pescara, Italy.
  • Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University, Chieti-Pescara, Italy.
  • Xellar Biosystems, Boston, MA, USA.
  • Department of Medical and Surgical Sciences, University of Foggia, Italy.
  • Unit of Cancer Cell Signalling, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy.
  • Department of Medicine, Division of General Pathology, University of Verona, Italy.

ORCID profiles: Domenico Mattoscio, Roberto Plebani

Funding

  • NCCIH NIH HHS
  • Fondazione per la Ricerca sulla Fibrosi Cistica
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Umberto Veronesi
  • Italian Ministry of Health (fund ex60%)
  • Fondazione AIRC per la ricerca sul cancro ETS

Cite

APA

Mattoscio, D., Baeza, L. A., Bai, H., Colangelo, T., Castagnozzi, S., Marzotto, M., Cufaro, M. C., Lotti, V., Yuan, Y. C., Mucci, M., Si, L., Zuccarini, M., Tredicine, M., D'Orazio, S., Pieragostino, D., Del Boccio, P., Sorio, C., Trerotola, M., Romano, M., & Plebani, R. (2025). Inflammation and epithelial–mesenchymal transition in a CFTR ‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip. The FEBS Journal, 292(19), 5086-5104. https://doi.org/10.1111/febs.70050

Vancouver

Mattoscio D, Baeza LA, Bai H, Colangelo T, Castagnozzi S, Marzotto M, et al. Inflammation and epithelial–mesenchymal transition in a CFTR ‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip. The FEBS Journal. 2025;292(19):5086-5104. doi:10.1111/febs.70050

BibTeX
@article{Mattoscio2025,
  author = {Mattoscio, Domenico and Baeza, Luis A and Bai, Haiqing and Colangelo, Tommaso and Castagnozzi, Simone and Marzotto, Marta and Cufaro, Maria Concetta and Lotti, Virginia and Yuan, Yu-Chieh and Mucci, Matteo and Si, Longlong and Zuccarini, Mariachiara and Tredicine, Maria and D'Orazio, Simona and Pieragostino, Damiana and Del Boccio, Piero and Sorio, Claudio and Trerotola, Marco and Romano, Mario and Plebani, Roberto},
  title = {Inflammation and epithelial–mesenchymal transition in a CFTR ‐depleted human bronchial epithelial cell line revealed by proteomics and human organ‐on‐a‐chip},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {19},
  pages = {5086--5104},
  doi = {10.1111/febs.70050}
}
Start for free →